PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsDexamethasone
Maxitrol, Ozurdex(dexamethasone)
/ Dexamethasone, Ciprodex, Decadron-la, Dexamethasone, Dexamethasone /, Dexamethasone / /, Dexasporin, Dextenza, Dexycu, Hemady, Maxidex, Maxitrol, Neodecadron, Neofordex, Ozurdex, Tobradex (dexamethasone) is a small molecule pharmaceutical. Dexamethasone was first approved as Hexadrol on 1982-01-01. It is used to treat addison disease, allergic rhinitis perennial, ankylosing spondylitis, brain edema, and bursitis amongst others in the USA. It has been approved in Europe to treat macular edema, multiple myeloma, and uveitis.
Download report
Favorite
COVID-19
Novartis Pharmaceuticals
Case Study: COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
neoplasmsD009369
musculoskeletal diseasesD009140
digestive system diseasesD004066
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
nervous system diseasesD009422
eye diseasesD005128
cardiovascular diseasesD002318
hemic and lymphatic diseasesD006425
Show 5 more
Trade Name
FDA
EMA
Dexamethasone, Dextenza, Dexycu, Hemady, Maxidex, Ozurdex (discontinued: Aeroseb-dex, Decaderm, Decadron, Decadron-la, Decaspray, Dexacen, Dexacort, Dexamethasone, Dexone, Hexadrol, Maxidex)
Combinations
Ciprodex, Ciprofloxacin dexamethasone, Dexasporin, Maxitrol, Neomycin polymyxin b sulfates dexamethasone, Tobradex, Tobramycin dexamethasone (discontinued: Decadron w/ xylocaine, Dexacidin, Neodecadron, Neomycin dexamethasone, Neomycin polymyxin b sulfates dexamethasone, Neomycin sulfate-dexamethasone, Tobramycin dexamethasone)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Dexamethasone
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
MAXITROLHarrowN-050023 RX1982-01-01
1 products, RLD, RS
MAXITROLSandozN-050065 RX1982-01-01
1 products, RLD, RS
Dexamethasone
Tradename
Company
Number
Date
Products
OZURDEXAbbVieN-022315 RX2009-06-17
1 products, RLD, RS
HEMADYDexcel PharmaN-211379 RX2019-10-03
1 products, RLD, RS
DEXYCU KITEyepoint PharmaceuticalsN-208912 RX2018-02-09
1 products, RLD, RS
MAXIDEXHarrowN-013422 RX1982-01-01
1 products, RLD, RS
DEXTENZAOcular TherapeutixN-208742 RX2018-11-30
1 products, RLD, RS
Show 6 discontinued
Dexamethasone
+
Tobramycin
Tradename
Company
Number
Date
Products
TOBRADEX STHarrowN-050818 RX2009-02-13
1 products, RLD, RS
TOBRADEXNovartisN-050616 RX1988-09-28
1 products, RLD, RS
TOBRADEXSandozN-050592 RX1988-08-18
1 products, RLD, RS
Dexamethasone acetate
Tradename
Company
Number
Date
Products
DECADRON-LAMerck & CoN-016675 DISCN1982-01-01
1 products, RLD
Hide discontinued
Ciprofloxacin
+
Dexamethasone
Tradename
Company
Number
Date
Products
CIPRODEXSandozN-021537 RX2003-07-18
1 products, RLD, RS
Dexamethasone sodium phosphate
Tradename
Company
Number
Date
Products
HEXADROLAspen GlobalN-014694 DISCN1982-01-01
3 products
DECADRONMerck & CoN-011983 DISCN1982-01-01
1 products
DECADRONMerck & CoN-012071 DISCN1982-01-01
2 products, RLD
DECADRONMerck & CoN-011977 DISCN1982-01-01
1 products
DECADRONMerck & CoN-011984 DISCN1982-01-01
1 products, RLD
DEXACORTUCBN-013413 DISCN1982-01-01
1 products
DEXACORTUCBN-014242 DISCN1982-01-01
1 products
Hide discontinued
Dexamethasone sodium phosphate
+
Lidocaine hydrochloride
Tradename
Company
Number
Date
Products
DECADRON W/ XYLOCAINEMerck & CoN-013334 DISCN1982-01-01
1 products
Hide discontinued
Dexamethasone sodium phosphate
+
Neomycin sulfate
Tradename
Company
Number
Date
Products
NEODECADRONMerck & CoN-050324 DISCN1982-01-01
1 products
NEODECADRONMerck & CoN-050322 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
baycadronANDA2009-07-15
ciprodexNew Drug Application2011-08-23
ciprofloxacin and dexamethasoneANDA2025-08-30
cortaren corticosteroid/anti-inflammatory systemANDA2022-02-24
decadronANDA2017-10-01
dex-moxiunapproved drug other2020-02-10
dex-moxi pfunapproved drug other2018-05-08
dex-moxi-ketorunapproved drug other2020-02-10
dexamethasoneANDA2025-11-21
dexamethasone 6-dayANDA2022-01-18
Show 38 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
leukemia—D007938C95
septic shock—D012772A48.3
wounds and injuries—D014947T14.8
ulcerative colitisEFO_0000729D003093K51
ankylosing spondylitisEFO_0003898D013167M45
vomiting—D014839R11.1
nausea—D009325R11.0
sarcoidosisEFO_0000690D012507D80-D89
gastrointestinal diseases—D005767—
thrombocytopenic purpura idiopathicEFO_0007160D016553D69.3
Show 63 more
Agency Specific
FDA
EMA
Expiration
Code
DEXAMETHASONE, HEMADY, DEXCEL
2026-10-03ODE-271
DEXAMETHASONE, DEXTENZA, OCULAR THERAPEUTIX
2024-10-07I-876
DEXAMETHASONE, DEXAMETHASONE, AMNEAL
2023-03-08CGT
Patent Expiration
Patent
Expires
Flag
FDA Information
Dexamethasone, Dexycu Kit, Eyepoint Pharms
110970612039-06-23DPU-3418
100225022034-06-22U-2340
100289652034-05-23U-2340
101596832034-05-23DP
107996422032-05-11DP
69603462023-07-03DP
Dexamethasone, Hemady, Dexcel
105375852037-12-18DP
113049612037-12-18DPU-3344
Dexamethasone, Dextenza, Ocular Therapeutix
114580412037-11-16U-1680, U-3455
84096062030-05-14DP
85630272030-02-12U-2487
92542672024-09-11DP
Dexamethasone / Tobramycin, Tobradex St, Eyevance
77953162028-08-03DPU-1082
81015822027-12-19DPU-1082
84502872027-12-19DP
Ciprofloxacin / Dexamethasone, Ciprodex, Novartis
88466502025-06-04DPU-1578
Dexamethasone, Ozurdex, Abbvie
68997172023-11-01U-1206
80343662023-01-09DPU-1204, U-1205
80343702023-01-09DP
85069872023-01-09U-1204, U-1205
91925112023-01-09DP
100765262023-01-09DP
107025392023-01-09U-985, U-1597, U-2868
ATC Codes
A: Alimentary tract and metabolism drugs
— A01: Stomatological preparations
— A01A: Stomatological preparations
— A01AC: Corticosteroids for local oral treatment
— A01AC02: Dexamethasone
C: Cardiovascular system drugs
— C05: Vasoprotectives
— C05A: Agents for treatment of hemorrhoids and anal fissures for topical use
— C05AA: Corticosteroids, topical for treatment of hemorrhoids and anal fissures
— C05AA09: Dexamethasone
D: Dermatologicals
— D07: Corticosteroids, dermatological preparations
— D07A: Corticosteroid dermatological preparations, plain
— D07AB: Corticosteroids, moderately potent (group ii)
— D07AB19: Dexamethasone
— D07C: Corticosteroids, combinations with antibiotics
— D07CB: Corticosteroids, moderately potent, combinations with antibiotics
— D07CB04: Dexamethasone and antibiotics
— D07X: Corticosteroids, other combinations
— D07XB: Corticosteroids, moderately potent, other combinations
— D07XB05: Dexamethasone
— D10: Anti-acne preparations
— D10A: Anti-acne preparations for topical use
— D10AA: Corticosteroids, combinations for treatment of acne
— D10AA03: Dexamethasone
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H02: Corticosteroids for systemic use
— H02A: Corticosteroids for systemic use, plain
— H02AB: Glucocorticoids, systemic
— H02AB02: Dexamethasone
R: Respiratory system drugs
— R01: Nasal preparations
— R01A: Decongestants and other nasal preparations for topical use
— R01AD: Corticosteroid nasal preparations for topical use
— R01AD03: Dexamethasone
— R01AD53: Dexamethasone, combinations
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01B: Antiinflammatory agents, ophthalmologic
— S01BA: Corticosteroid ophthalmologic antiinflammatory agents, plain
— S01BA01: Dexamethasone
— S01C: Antiinflammatory agents and antiinfectives in combination
— S01CA: Corticosteroids and antiinfectives in combination, opthalmologic
— S01CA01: Dexamethasone and antiinfectives
— S01CB: Corticosteroids/antiinfectives/mydriatics in combination
— S01CB01: Dexamethasone
— S02: Otologicals
— S02B: Corticosteroid otologicals
— S02BA: Corticosteroids
— S02BA06: Dexamethasone
— S02C: Corticosteroids and antiinfectives in combination, otologic
— S02CA: Corticosteroids and antiinfectives in combination
— S02CA06: Dexamethasone and antiinfectives
— S03: Ophthalmological and otological preparations
— S03B: Corticosteroid ophthalmologic and otologic preparations
— S03BA: Corticosteroids
— S03BA01: Dexamethasone
— S03C: Corticosteroids and antiinfectives in combination, opthalmologic and otologic
— S03CA: Corticosteroids and antiinfectives in combination
— S03CA01: Dexamethasone and antiinfectives
HCPCS
Code
Description
J1094
Injection, dexamethasone acetate, 1 mg
J1095
Injection, dexamethasone 9 percent, intraocular, 1 microgram
J1096
Dexamethasone, lacrimal ophthalmic insert, 0.1 mg
J1100
Injection, dexamethasone sodium phosphate, 1 mg
J7312
Injection, dexamethasone, intravitreal implant, 0.1 mg
J7637
Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7638
Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
J8540
Dexamethasone, oral, 0.25 mg
Clinical
Clinical Trials
4471 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular edemaD008269————1135
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101—C90.012147—129
Plasma cell neoplasmsD054219——893—118
Lung neoplasmsD008175—C34.90——3——3
Small cell lung carcinomaD055752————3——3
LymphomaD008223—C85.9111——3
EdemaD004487—R60.9——1—23
Disease progressionD018450————1——1
Covid-19D000086382—U07.1——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C8055———7
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.052———5
LeukemiaD007938—C9531———3
Precursor t-cell lymphoblastic leukemia-lymphomaD054218——22———3
RecurrenceD012008——21———2
Biphenotypic leukemia acuteD015456—C95.011———2
Precursor b-cell lymphoblastic leukemia-lymphomaD015452——21———2
Prostatic neoplasmsD011471—C6111———1
CarcinomaD002277—C80.011———1
Pancreatic neoplasmsD010190EFO_0003860C2511———1
Show 10 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470—C92.02————2
Non-hodgkin lymphomaD008228—C85.92————2
B-cell lymphomaD016393——2————2
NeuroblastomaD009447EFO_0000621—1————1
Lymphoid leukemiaD007945—C911————1
Myelodysplastic syndromesD009190—D461————1
Neoplasm metastasisD009362EFO_0009708—1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E13————11
Retinal vein occlusionD012170EFO_1001157H34.81————11
Vascular diseasesD014652EFO_0004264I77————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDexamethasone
INNdexamethasone
Description
Dexamethasone is a fluorinated steroid that is 9-fluoropregna-1,4-diene substituted by hydroxy groups at positions 11, 17 and 21, a methyl group at position 16 and oxo groups at positions 3 and 20. It is a synthetic member of the class of glucocorticoids. It has a role as an adrenergic agent, an antiemetic, an antineoplastic agent, an environmental contaminant, a xenobiotic, an immunosuppressive agent and an anti-inflammatory drug. It is a fluorinated steroid, a 3-oxo-Delta(1),Delta(4)-steroid, a glucocorticoid, a 20-oxo steroid, an 11beta-hydroxy steroid, a 17alpha-hydroxy steroid and a 21-hydroxy steroid. It derives from a hydride of a pregnane.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
Identifiers
PDB—
CAS-ID50-02-2
RxCUI—
ChEMBL IDCHEMBL384467
ChEBI ID41879
PubChem CID5743
DrugBankDB01234
UNII ID7S5I7G3JQL (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Ozurdex – Allergan
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Ozurdex – Warner Chilcott
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Ozurdex – AbbVie
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Dexamethasone
+
Ciprofloxacin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Dexamethasone
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Dexamethasone
+
Moxifloxacin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Dexamethasone
+
Neomycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Dexamethasone
+
Neomycin
+
Polymyxin b
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Dexamethasone
+
Tobramycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 126,408 documents
View more details
Safety
Black-box Warning
Black-box warning for: Dexlido-m kit, Mardex 25 kit
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
154,554 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use